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rug-Eluting Stents
areful Deployment Required*
aran S. Bhalla, MD, H. Vernon Anderson, MD
ouston, Texas
he question of adequate deployment or optimal expansion
f coronary stents has been with us since the very beginning.
n the one hand, it is well documented that stent under-
xpansion, or malapposition, both for bare-metal stents as
ell as drug-eluting stents (DES), is related to adverse
vents including stent thrombosis and stent restenosis (1–3).
et, on the other hand, overexpansion of a stent is not
ithout its problems, such as compromise of jailed side
ranches, strut fracture, and distal and proximal dissections
eopardizing large branches. So although most intervention-
lists deploy a stent at high pressure, or post-dilate a stent
ith high pressure balloons at least once, there likely is a
uite natural hesitation not to overexpand the stent in doing
his. Moreover with DES, there may also be a complacency
hat has grown up to “let the drugs do their work.” That is,
ust get the stent struts into contact with the arterial wall in
he expectation that neointimal hyperplasia will be inhib-
ted, and the antiplatelet therapies will prevent any stent
hrombosis. Taking the time to expand a coronary stent to
ts completely adequate and optimized size, using extra
ngiographic injections or intravascular ultrasound (IVUS)
o assess and reassess the results several times over, perhaps
as come to be seen as an unnecessarily time-consuming
nd possibly dangerous practice.
See page 428
Proponents of IVUS have long suggested its routine use in
tent procedures to check for adequate deployment. To its
reat credit, IVUS has yielded many critical insights into
echanisms of arterial wall injury and healing responses, as
ell as stent-vessel wall interactions (4). Generally speaking,
hen post-deployment IVUS is performed after stenting, it
eads to more frequent post-deployment dilations using more
igher-pressure balloons. This is 1 way to help achieve ade-
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.q
From the Cardiology Division, University of Texas Health Science Center,
ouston, Texas.uate stent expansion and avoid underexpansion. Yet propo-
ents of angiography-only for stent deployment point out the
ncreased procedure time and extra costs associated with
outine IVUS use, along with the multiplicity of definitions, its
navailability in many institutions, and the lack of randomized
rial data showing any clinical benefit (5).
In this issue of JACC: Cardiovascular Interventions, Liu et
l. (6), from the Cardiovascular Research Foundation at
olumbia University, have added a small but important
dditional piece to a very complicated puzzle. They identi-
ed from their extensive database 3 groups of patients: a
roup of 20 patients with definite DES thrombosis, a group
f 50 risk-factor-balanced patients with DES restenosis but
o thrombosis, and another group of 50 risk-factor-
alanced patients with neither of these outcomes. Of note,
he time interval from DES implantation until stent throm-
osis was a median of 9 days in that group, so these were
ostly early stent thrombosis cases, although it was a
kewed distribution and some thrombosis events did occur
ater. The median follow-up intervals for the other 2 groups
restenosis and event-free) were both a little over 8 months,
hich is sufficient. The main finding was that there was a
radation in adequacy of DES expansion as assessed using
VUS. The group with the least adequate stent expansion
most underexpansion) was the DES thrombosis group. At
he other extreme, the group with the most adequate DES
xpansion (least underexpansion) was the group with no
vents. The DES restenosis group occupied a middle
osition in terms of expansion adequacy. The analysis also
uggested that there was a gradation in diffuseness of DES
xpansion across the 3 groups, with more diffuse underex-
ansion found in the thrombosis group.
The final finding that is of note here was that the proximal
egments of the stents were more underexpanded than the
istal segments. This might suggest that the natural tendency
s to “size” the stent to the distal arterial dimensions alone and
ay less attention to the more proximal arterial dimensions.
hus the initial stent deployment and any post-dilations that
re done are aimed to ensure that adequate stent expansion is
chieved at the distal edges, perhaps leaving the proximal stent
egments underexpanded in relation to the vessel wall. Given
he commonplace fears of arterial dissections due to overex-
ansion in the distal segments, this unilateral focus of attention
ould not be unexpected.
What can 120 coronary stent cases teach us? The current
aper by Liu et al. (6) serves as a reminder that proper stent
eployment techniques are forever necessary. Good clinical
esults depend not only upon the drugs we use, whether the
ntiproliferatives on the DES or the antiplatelet agents
aken orally, but also depend on taking the necessary time to
o the procedure carefully. Inadequate deployment is re-
ponsible for at least some of the adverse clinical events of
hrombosis and restenosis that continue to haunt us. Ade-
uate stent expansion throughout the entire stent length
m
I
I
t
o
g
s
a
a
d
t
s
s
t
T
a
c
c
i
R
C
6
h
R
1
2
3
4
5
6
7
8
K
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 5 , 2 0 0 9
M A Y 2 0 0 9 : 4 3 5 – 6
Bhalla and Anderson
Editorial Comment
436ust be the goal. All of this might mean a greater use of
VUS to check for optimal stent expansion. The devotees of
VUS will continue to champion this approach, and for
hose who prefer IVUS but have been constrained by
utside forces, the justification for IVUS has never been
reater. For those who prefer angiography, it might mean
pending additional minutes studying the post-deployment
ngiogram carefully, or perhaps obtaining 1 or 2 additional
ngiographic views and studying them in equally great
etail. It likewise seems reasonable to pay more attention to
he adequacy of stent expansion in the proximal stent
egments. There are pre-clinical and early clinical data
uggesting that a more prolonged stent delivery inflation
ime (60 s) can help achieve optimal DES expansion (7,8).
his needs to be confirmed in larger series but is a newer
pproach. Only by taking the necessary time and paying
lose attention to detail will we be able to reduce the
ontribution that inadequate DES expansion makes to these
nsidious phenomena.
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